Condition
Metabolic Health
Metabolic health describes how well your body turns food into energy, including how it handles blood sugar, insulin and fats. Among supplements, the evidence is strongest for beta-glucans, a fiber found in oats, where three studies of 538 people found blood glucose improved. MOTS-c, a mitochondrial peptide, also looked promising for insulin sensitivity, but mostly in mice, so what it means for people is unclear.
Sources: PMID 33608654; PMID 26001090; PMID 25738459
- Updated
- How we grade
- 100 studies cited
- Supplements studied
- 132
- Medicines and peptides
- 7
- Graded outcomes
- 154
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 3 studies | 538 people | ||
Studies that measured blood glucose
| ||||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline Small Increase | Improves (the measure goes up) | Small effect | 2 studies | 42 people | ||
Panax Ginseng (Korean Ginseng)
- Anti-Oxidant Enzyme Profile: improves
- Cognition: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 2 studies | 139 people | ||
Studies that measured anti-oxidant enzyme profile
| ||||||
| Cognition | Improves (the measure goes up) | 9 studies | 30 people | |||
Studies that measured cognition
| ||||||
| Blood glucose | Improves (the measure goes down) | 3 studies | 124 people | |||
Studies that measured blood glucose
| ||||||
| Insulin | Changes; see studies | 3 studies | 182 people | |||
Studies that measured insulin
| ||||||
| HbA1c | Improves (the measure goes down) | 2 studies | 476 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 18 people | |||
| Inflammation | Improves (the measure goes down) | 1 study | 18 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 20 people | |||
| Blood Pressure | Improves (the measure goes down) | 702 people | ||||
| Body Fat | Improves (the measure goes down) | 106 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 20 people | ||||
| Cortisol | Improves (the measure goes down) | 20 people | ||||
| DNA Damage | Changes; see studies | 57 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 753 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 57 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 657 people | ||||
| Muscle Damage | Changes; see studies | 18 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 82 people | ||||
| Strength | Improves (the measure goes up) | 20 people | ||||
| Total cholesterol | Improves (the measure goes down) | 803 people | ||||
| Triglycerides | Improves (the measure goes down) | 741 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 20 people | ||||
| Weight | Improves (the measure goes down) | 57 people | ||||
Alpha-GPC
- Growth Hormone: improves
- Fat Oxidation: improves
- Iron Absorption: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Growth Hormone Small Increase | Improves (the measure goes up) | Small effect | 1 study | 15 people | ||
Studies that measured growth hormone | ||||||
| Fat Oxidation Small Increase | Improves (the measure goes up) | Small effect | 8 people | |||
| Iron Absorption | Improves (the measure goes up) | 2 studies | 114 people | |||
Probiotics
- Blood glucose: improves
- HbA1c: improves
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 450 people | ||
| HbA1c | Improves (the measure goes down) | 2 studies | 671 people | |||
Studies that measured hba1c
| ||||||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 389 people | |||
Studies that measured insulin resistance | ||||||
| Testosterone | Improves (the measure goes up) | 1 study | 47 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 363 people | |||
| Blood Pressure | Improves (the measure goes down) | 306 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 363 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 47 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 433 people | ||||
| Insulin | Changes; see studies | 424 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 433 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 47 people | ||||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 47 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 47 people | ||||
| Triglycerides | Improves (the measure goes down) | 433 people | ||||
Ellagic Acid
- Blood glucose: improves
- Body Mass Index (BMI): improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 284 people | ||
Studies that measured blood glucose | ||||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 422 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 316 people | ||||
| Insulin | Changes; see studies | 229 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 143 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 252 people | ||||
| Total cholesterol | Improves (the measure goes down) | 183 people | ||||
| Triglycerides | Improves (the measure goes down) | 284 people | ||||
| Weight | Improves (the measure goes down) | 399 people | ||||
Milk Protein
- Blood glucose
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Mixed effect | 1 study | 2,750 people | ||||
| Insulin | Changes; see studies | 2,750 people | ||||
Niacin (Vitamin B3)
- Adiponectin: improves
- Adrenaline
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Moderate Increase | Improves (the measure goes up) | Moderate effect | 1 study | 288 people | ||
Studies that measured adiponectin | ||||||
| Adrenaline No effect | NoneNo effect | 12 people | ||||
| Insulin | Changes; see studies | 2 studies | 160 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 2 studies | 37 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 30 people | |||
| Apolipoprotein A | Improves (the measure goes up) | 1 study | 30 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 103 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 37 people | |||
| Ketone Bodies | Improves (the measure goes up) | 1 study | 12 people | |||
| Blood Flow | Improves (the measure goes up) | 37 people | ||||
| Blood Pressure | Improves (the measure goes down) | 7 people | ||||
| Body Fat | Improves (the measure goes down) | 7 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 616 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 30 people | ||||
| Cortisol | Improves (the measure goes down) | 12 people | ||||
| Fat Oxidation | Improves (the measure goes up) | 7 people | ||||
| Glucagon | Changes; see studies | 12 people | ||||
| Glycemic Control | Improves (the measure goes up) | 46 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 30 people | ||||
| Leptin | Improves (the measure goes up) | 165 people | ||||
| Liver Enzymes | Changes; see studies | 30 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 7 people | ||||
| Plasma Nitrate | Improves (the measure goes up) | 7 people | ||||
| Resistin | Improves (the measure goes up) | 30 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 30 people | ||||
| Triglycerides | Improves (the measure goes down) | 37 people | ||||
| Weight | Improves (the measure goes down) | 7 people | ||||
Propolis
- Blood glucose: improves
- HbA1c: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 1,072 people | ||
| HbA1c | Improves (the measure goes down) | 1,072 people | ||||
| Insulin | Changes; see studies | 1,072 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 1,072 people | ||||
| Liver Enzymes | Changes; see studies | 1,072 people | ||||
Pycnogenol
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 838 people | ||
Studies that measured blood glucose | ||||||
Psyllium
- Blood glucose: improves
- HbA1c: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 962 people | ||
| HbA1c | Improves (the measure goes down) | 1 study | 523 people | |||
| Insulin | Changes; see studies | 575 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 591 people | ||||
Citrus Bergamot (Bergamot Polyphenolic Fraction)
- Metabolic Parameters: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Metabolic Parameters Clinical studies suggest improvements in insulin sensitivity and NAFLD indices. Bergamot activates AMPK pathway affecting glucose and lipid metabolism. Some studies show reductions in fasting glucose. More research needed for definitive conclusions. | Improves (the measure goes up) | Small effect |
Exogenous Ketones
- Blood glucose: improves
- Ketone Bodies: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 586 people | |||
| Ketone Bodies | Improves (the measure goes up) | 1 study | 586 people |
Iron
- Anemia Risk: improves
- Hemoglobin: improves
- Ferritin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anemia Risk Small Improvement | Improves (the measure goes down) | Small effect | 34,564 people | |||
| Hemoglobin | Improves (the measure goes up) | 7 studies | 1,120 people | |||
| Ferritin | Improves (the measure goes up) | 1,170 people | ||||
| Iron Deficiency Anemia Risk | Changes; see studies | 34,564 people | ||||
| Iron Deficiency Risk | Changes; see studies | 34,564 people | ||||
| Serum Iron | Improves (the measure goes up) | 67 people | ||||
| Total Iron Binding Capacity | Improves (the measure goes up) | 67 people | ||||
| Transferrin | Improves (the measure goes up) | 334 people |
Spirulina
- Anti-Oxidant Enzyme Profile: improves
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 108 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 5 studies | 156 people | |||
| Total cholesterol | Improves (the measure goes down) | 5 studies | 156 people | |||
| Interleukin 6 | Improves (the measure goes down) | 3 studies | 78 people | |||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 2 studies | 108 people | |||
| Muscular Endurance | Improves (the measure goes up) | 1 study | 9 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 195 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 197 people | |||
| Fat Oxidation | Improves (the measure goes up) | 9 people | ||||
| Glutathione (GSH) | Improves (the measure goes up) | 30 people | ||||
| Glutathione Reductase | Improves (the measure goes up) | 30 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 156 people | ||||
| Plasma Vitamin C | Improves (the measure goes up) | 30 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 78 people |
Cornelian Cherry Extract
- Blood glucose: improves
- Weight: improves
- Body Mass Index (BMI): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 215 people | |||
| Weight | Improves (the measure goes down) | 1 study | 305 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 315 people | ||||
| HbA1c | Improves (the measure goes down) | 231 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 415 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 255 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 415 people | ||||
| Total cholesterol | Improves (the measure goes down) | 415 people | ||||
| Triglycerides | Improves (the measure goes down) | 415 people | ||||
| Waist circumference | Improves (the measure goes down) | 415 people |
Fiber
- High-density lipoprotein (HDL): improves
- Total cholesterol: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) Small Improvement | Improves (the measure goes up) | Small effect | 291 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 334 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 334 people | ||||
| Triglycerides | Improves (the measure goes down) | 311 people |
Salacia Reticulata
- Blood glucose: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Moderate Improvement | Improves (the measure goes down) | Moderate effect | 82 people | |||
| Insulin | Changes; see studies | 3 studies | 82 people |
Folic Acid (Vitamin B9)
- C-Reactive Protein (CRP): improves
- TNF-Alpha: improves
- Serum Folate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1,482 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 962 people | |||
| Serum Folate | Improves (the measure goes up) | 1 study | 2,341 people | |||
| Interleukin 6 | Improves (the measure goes down) | 1,021 people |
Magnesium
- Blood glucose: improves
- Blood Pressure: improves
- Serum Magnesium: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 17 studies | 334 people | ||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 304 people | |||
| Serum Magnesium | Improves (the measure goes up) | 6 studies | 416 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 3 studies | 737 people | |||
| Cortisol | Improves (the measure goes down) | 2 studies | 30 people | |||
| Triglycerides | Improves (the measure goes down) | 2 studies | 304 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 60 people | |||
| Glutathione (GSH) | Improves (the measure goes up) | 194 people | ||||
| Glycemic Control | Improves (the measure goes up) | 304 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 304 people | ||||
| Insulin | Changes; see studies | 334 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 142 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 207 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 194 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 194 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 112 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 235 people | ||||
| Total cholesterol | Improves (the measure goes down) | 207 people | ||||
| Weight | Improves (the measure goes down) | 304 people |
Sodium Bicarbonate
- Anaerobic Capacity: improves
- Serum Bicarbonate: improves
- Blood Acidity: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity Small Improvement | Improves (the measure goes up) | Small effect | 11 studies | 22 people | ||
| Serum Bicarbonate | Improves (the measure goes up) | 26 studies | 63 people | |||
| Blood Acidity | Changes; see studies | 4 studies | 216 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 2 studies | 22 people | |||
| Insulin | Changes; see studies | 2 studies | 159 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 8 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 171 people | |||
| Training Volume | Improves (the measure goes up) | 1 study | 10 people | |||
| Blood glucose | Improves (the measure goes down) | 153 people | ||||
| Ketone Bodies | Improves (the measure goes up) | 24 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 8 people | ||||
| Weight | Improves (the measure goes down) | 10 people |
Saffron
- Blood glucose: improves
- Blood Pressure: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 6 studies | 1,674 people | ||
| Blood Pressure | Improves (the measure goes down) | 3 studies | 1,674 people | |||
| Weight | Improves (the measure goes down) | 3 studies | ||||
| Triglycerides | Improves (the measure goes down) | 2 studies | 1,674 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 1,674 people | |||
| LDL Oxidation | Improves (the measure goes down) | 1 study | 20 people | |||
| HbA1c | Improves (the measure goes down) | 1,674 people | ||||
| Insulin | Changes; see studies | 1,674 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 1,674 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1,674 people | ||||
| Total cholesterol | Improves (the measure goes down) | 1,674 people |
Medium-chain Triglycerides
- Fat Oxidation: improves
- Metabolic Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fat Oxidation Small Increase | Improves (the measure goes up) | Small effect | 3 studies | 12 people | ||
| Metabolic Rate | Improves (the measure goes up) | 2 studies | 12 people |
Boron
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Moderate Decrease | Improves (the measure goes down) | Moderate effect | 3 studies | 8 people |
Fenugreek
- Appetite
- Blood glucose: improves
- Estrogen: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Appetite Mixed effect | 2 studies | 20 people | ||||
| Blood glucose | Improves (the measure goes down) | 4 studies | 20 people | |||
| Estrogen | Changes; see studies | 2 studies | 45 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 517 people | |||
| Insulin | Changes; see studies | 1 study | 45 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 550 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 366 people | ||||
| Cortisol | Improves (the measure goes down) | 45 people | ||||
| DHT | Improves (the measure goes up) | 45 people | ||||
| Leptin | Improves (the measure goes up) | 45 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 371 people | ||||
| Testosterone | Improves (the measure goes up) | 45 people | ||||
| Triglycerides | Improves (the measure goes down) | 550 people | ||||
| Weight | Improves (the measure goes down) | 387 people |
Theanine
- Anxiety Symptoms: improves
- Heart Rate: improves
- Stress Signs and Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 12 people | ||
| Heart Rate | Improves (the measure goes down) | 1 study | 12 people | |||
| Stress Signs and Symptoms | Improves (the measure goes down) | 1 study | 12 people |
Policosanol
- LDL Oxidation: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| LDL Oxidation Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 69 people | ||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 studies | 21 people |
Ephedrine
- Body Fat: improves
- Weight: improves
- Metabolic Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Moderate Decrease | Improves (the measure goes down) | Moderate effect | 1 study | 57 people | ||
| Weight | Improves (the measure goes down) | 9 studies | 57 people | |||
| Metabolic Rate | Improves (the measure goes up) | 5 studies | 24 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 57 people | ||||
| Triglycerides | Improves (the measure goes down) | 57 people |
Zinc
- C-Reactive Protein (CRP): improves
- Iron Absorption: improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 40 people | ||
| Iron Absorption | Improves (the measure goes up) | 4 studies | 28 people | |||
| Testosterone | Improves (the measure goes up) | 3 studies | 10 people | |||
| Cell Adhesion Factors | Improves (the measure goes down) | 1 study | 40 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 40 people | |||
| Free Testosterone | Improves (the measure goes up) | 10 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 40 people | ||||
| Serum T3 | Improves (the measure goes up) | 10 people | ||||
| Serum T4 | Improves (the measure goes up) | 10 people |
Lemon Balm
- DNA Damage: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA Damage Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 55 people | ||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 55 people |
Schisandra
- Cortisol
- Nitric Oxide: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cortisol Mixed effect | 1 study | 71 people | ||||
| Nitric Oxide Small Increase | Improves (the measure goes up) | Small effect | 71 people |
N-Acetylcysteine
- Anaerobic Capacity: improves
- Mineral Bioaccumulation: improves
- Anti-Oxidant Enzyme Profile: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 12 people | ||
| Mineral Bioaccumulation | Improves (the measure goes up) | 1 study | 171 people | |||
| Anti-Oxidant Enzyme Profile | Improves (the measure goes up) | 171 people |
Cannabis
- Cortisol
- Heart Rate: improves
- Ghrelin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cortisol Mixed effect | 1 study | 12 people | ||||
| Heart Rate | Improves (the measure goes down) | 4 studies | 8 people | |||
| Ghrelin | Improves (the measure goes up) | 2 studies | 20 people | |||
| Leptin | Improves (the measure goes up) | 1 study | 20 people | |||
| Metabolic Rate | Improves (the measure goes up) | 1 study | 8 people | |||
| Prolactin | Improves (the measure goes up) | 1 study | 23 people | |||
| Glucagon-like peptide 1 (GLP-1) | Improves (the measure goes up) | 20 people |
Shilajit
- Anti-Oxidant Enzyme Profile: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 45 people |
Iodine
- C-Reactive Protein (CRP): improves
- Interleukin 6: improves
- Thyroid-Stimulating Hormone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 30 people | ||
| Interleukin 6 Small Decrease | Improves (the measure goes down) | Small effect | 30 people | |||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 3 studies | 30 people | |||
| Serum T3 | Improves (the measure goes up) | 1 study | 60 people | |||
| Serum T4 | Improves (the measure goes up) | 60 people |
Ornithine
- Cortisol
- Fatigue Symptoms: improves
- Sleep Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cortisol Mixed effect | 1 study | 27 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 27 people | ||||
| Sleep Quality | Improves (the measure goes up) | 27 people |
Licorice
- LDL Oxidation: improves
- Estrogen
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| LDL Oxidation Moderate Improvement | Improves (the measure goes down) | Moderate effect | 1 study | 19 people | ||
| Estrogen No effect | NoneNo effect | 1 study | 9 people | |||
| Testosterone | Improves (the measure goes up) | 4 studies | 33 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 19 people | |||
| Parathyroid Hormone | Improves (the measure goes up) | 9 people |
Rooibos
- High-density lipoprotein (HDL): improves
- Blood glucose
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 15 people | ||
| Blood glucose Mixed effect | 15 people | |||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 15 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 27 people | ||||
| Total cholesterol | Improves (the measure goes down) | 15 people | ||||
| Triglycerides | Improves (the measure goes down) | 15 people | ||||
| Uric Acid | Improves (the measure goes down) | 15 people |
Chia seeds
- Appetite: improves
- Blood glucose
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Appetite Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 11 people | ||
| Blood glucose No effect | NoneNo effect | 1 study | 362 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 76 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 76 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 76 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 76 people | |||
| HbA1c | Improves (the measure goes down) | 362 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 76 people | ||||
| Inflammation | Improves (the measure goes down) | 76 people | ||||
| Insulin | Changes; see studies | 362 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 76 people |
Roselle
- Inflammation: improves
- Oxidative Stress Biomarkers: improves
- Uric Acid: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 8 people | ||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 8 people | |||
| Uric Acid | Improves (the measure goes down) | 8 people |
Chlorella
- Anti-Oxidant Enzyme Profile: improves
- Blood Pressure: improves
- DNA Damage: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 1 study | 52 people | ||
| Blood Pressure | Improves (the measure goes down) | 3 studies | 52 people | |||
| DNA Damage | Changes; see studies | 52 people |
Grape Seed Extract
- Food Intake: improves
- High-density lipoprotein (HDL): improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Food Intake Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 51 people | ||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 24 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 44 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 24 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 24 people | ||||
| Total cholesterol | Improves (the measure goes down) | 24 people |
Capsaicin
- Blood glucose: improves
- Fat Oxidation: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 12 people | ||
| Fat Oxidation Small Increase | Improves (the measure goes up) | Small effect | 10 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 10 people | |||
| Insulin | Changes; see studies | 12 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 10 people |
Phosphatidylserine
- Cognition: improves
- Cortisol: improves
- Fatigue Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 18 people | ||
| Cortisol | Improves (the measure goes down) | 1 study | 18 people | |||
| Fatigue Symptoms | Improves (the measure goes down) | 1 study | 18 people | |||
| Processing Accuracy | Improves (the measure goes up) | 18 people | ||||
| Testosterone | Improves (the measure goes up) | 18 people |
MSM
- Muscle Damage: improves
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Muscle Damage Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 18 people | ||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 18 people |
Creatine
- Blood glucose: improves
- Muscle Creatine Content: improves
- Swimming Performance Metrics: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 144 people | ||
| Muscle Creatine Content | Improves (the measure goes up) | 11 studies | 74 people | |||
| Swimming Performance Metrics | Improves (the measure goes up) | 7 studies | 40 people | |||
| Muscle Mass | Improves (the measure goes up) | 5 studies | 33 people | |||
| Creatinine | Improves (the measure goes up) | 3 studies | 26 people | |||
| IGF-1 | Improves (the measure goes up) | 2 studies | 33 people | |||
| Insulin | Changes; see studies | 2 studies | 70 people | |||
| Oxygen Uptake | Improves (the measure goes up) | 2 studies | 18 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 48 people | |||
| Food Intake | Changes; see studies | 1 study | 22 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 22 people | |||
| Growth Hormone | Improves (the measure goes up) | 1 study | 46 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1 study | 26 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 18 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 99 people | |||
| Cortisol | Improves (the measure goes down) | 46 people | ||||
| DHT | Improves (the measure goes up) | 20 people | ||||
| Glycogen | Improves (the measure goes up) | 22 people | ||||
| Glycogen Resynthesis | Improves (the measure goes up) | 20 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 26 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 108 people | ||||
| Liver Enzymes | Changes; see studies | 26 people | ||||
| Triglycerides | Improves (the measure goes down) | 26 people | ||||
| Urea | Improves (the measure goes up) | 26 people |
Astaxanthin
- Anti-Oxidant Enzyme Profile: improves
- Arterial Stiffness
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Moderate Increase | Improves (the measure goes up) | Moderate effect | 39 people | |||
| Arterial Stiffness No effect | NoneNo effect | 61 people |
Green Coffee Extract
- Body Fat: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 30 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 30 people |
Coleus forskohlii
- Fatigue Symptoms: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fatigue Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 23 people | |||
| Weight | Improves (the measure goes down) | 3 studies | 23 people |
L-Tyrosine
- Adrenaline
- Heart Rate: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline Mixed effect | 32 people | |||||
| Heart Rate | Improves (the measure goes down) | 5 studies | 26 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 14 people | |||
| Dopamine | Improves (the measure goes up) | 1 study | 20 people | |||
| Renin Activity | Improves (the measure goes up) | 1 study | 12 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 14 people | ||||
| Blood Pressure | Improves (the measure goes down) | 12 people | ||||
| Noradrenaline | Improves (the measure goes up) | 32 people |
Arachidonic Acid
- Anaerobic Capacity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity Small Improvement | Improves (the measure goes up) | Small effect | 31 people |
Fisetin
- Oxidative Stress Markers: improves
- Fasting Blood Glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Oxidative Stress Markers Small reduction in oxidative stress | Improves (the measure goes down) | Small effect | 72 people | |||
| Fasting Blood Glucose Minor reduction in glucose levels | Improves (the measure goes down) | Small effect | 48 people |
Ashwagandha
- Anti-Oxidant Enzyme Profile: improves
- Blood glucose: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 30 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 17 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 17 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 30 people | |||
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 17 people | |||
| Body Fat | Improves (the measure goes down) | 17 people | ||||
| Liver Enzymes | Changes; see studies | 17 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 17 people | ||||
| Muscle Mass | Improves (the measure goes up) | 17 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 17 people | ||||
| Total cholesterol | Improves (the measure goes down) | 17 people | ||||
| Triglycerides | Improves (the measure goes down) | 17 people | ||||
| Weight | Improves (the measure goes down) | 17 people |
Korean black raspberry
- Anti-Oxidant Enzyme Profile: improves
- Blood glucose
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 15 people | |||
| Blood glucose No effect | NoneNo effect | 9 people | ||||
| Triglycerides | Improves (the measure goes down) | 1 study | 15 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 9 people | ||||
| HbA1c | Improves (the measure goes down) | 9 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 15 people | ||||
| Insulin | Changes; see studies | 9 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 9 people | ||||
| Liver Enzymes | Changes; see studies | 15 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 15 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 15 people | ||||
| Testosterone | Improves (the measure goes up) | 15 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 9 people | ||||
| Total cholesterol | Improves (the measure goes down) | 15 people |
Sea Buckthorn
- Carbohydrate Absorption: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Carbohydrate Absorption Small Decrease | Improves (the measure goes down) | Small effect | 10 people | |||
| Insulin | Changes; see studies | 1 study | 10 people |
Chlorogenic Acid
- Glycemic Control: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control Small Improvement | Improves (the measure goes up) | Small effect | 30 people | |||
| Weight | Improves (the measure goes down) | 1 study | 30 people |
Maca
- Anxiety Symptoms: improves
- Follicle-Stimulating Hormone: improves
- Sexual Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 16 people | |||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 3 studies | 16 people | |||
| Sexual Function | Improves (the measure goes up) | 2 studies | 16 people | |||
| Estrogen | Changes; see studies | 1 study | 16 people | |||
| Blood glucose | Improves (the measure goes down) | 197 people | ||||
| Blood Pressure | Improves (the measure goes down) | 197 people | ||||
| Depression Symptoms | Improves (the measure goes down) | 16 people | ||||
| Fatigue Symptoms | Improves (the measure goes down) | 197 people | ||||
| Hemoglobin | Improves (the measure goes up) | 197 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 16 people | ||||
| Menopausal Symptoms | Improves (the measure goes down) | 16 people | ||||
| Quality of Life | Improves (the measure goes up) | 197 people | ||||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 16 people |
Roselle
- Inflammation: improves
- Oxidative Stress Biomarkers: improves
- Uric Acid: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation Small Decrease | Improves (the measure goes down) | Small effect | 8 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 8 people | ||||
| Uric Acid | Improves (the measure goes down) | 8 people |
HMB
- Blood glucose: improves
- Muscle Mass: improves
- Body Fat: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 8 people | |||
| Muscle Mass | Improves (the measure goes up) | 8 studies | 8 people | |||
| Body Fat | Improves (the measure goes down) | 1 study | 8 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 421 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 421 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 8 people | ||||
| Total cholesterol | Improves (the measure goes down) | 421 people | ||||
| Triglycerides | Improves (the measure goes down) | 421 people | ||||
| Urea | Improves (the measure goes up) | 8 people |
Royal Jelly
- Blood glucose: improves
- Blood Pressure
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 71 people | |||
| Blood Pressure No effect | NoneNo effect | 56 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 71 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 56 people | |||
| Estrogen | Changes; see studies | 56 people | ||||
| Glycemic Control | Improves (the measure goes up) | 56 people | ||||
| HbA1c | Improves (the measure goes down) | 56 people | ||||
| Liver Enzymes | Changes; see studies | 15 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 71 people | ||||
| Total cholesterol | Improves (the measure goes down) | 15 people | ||||
| Triglycerides | Improves (the measure goes down) | 71 people | ||||
| Weight | Improves (the measure goes down) | 56 people |
Berberine
- Blood glucose: improves
- Total cholesterol: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Large Improvement | Improves (the measure goes down) | Large effect | 1,449 people | |||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 1,297 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2 studies | 1,133 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 1,231 people | |||
| Insulin Resistance | Improves (the measure goes down) | 471 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1,233 people |
Whey Protein
- Anti-Oxidant Enzyme Profile: improves
- Blood Flow
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 30 people | |||
| Blood Flow No effect | NoneNo effect | 20 people | ||||
| Insulin | Changes; see studies | 7 studies | 768 people | |||
| Weight | Improves (the measure goes down) | 4 studies | 100 people | |||
| Body Fat | Improves (the measure goes down) | 2 studies | 70 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 617 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2 studies | 939 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 850 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 50 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 70 people | |||
| Inflammation | Improves (the measure goes down) | 1 study | 20 people | |||
| Interleukin 6 | Improves (the measure goes down) | 1 study | 481 people | |||
| Gastric Emptying Rate | Changes; see studies | 81 people | ||||
| Glucagon-like peptide 1 (GLP-1) | Improves (the measure goes up) | 133 people | ||||
| HbA1c | Improves (the measure goes down) | 246 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 807 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 827 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 648 people | ||||
| Total cholesterol | Improves (the measure goes down) | 901 people | ||||
| Total-/HDL-cholesterol ratio | Changes; see studies | 161 people | ||||
| Triglycerides | Improves (the measure goes down) | 1,018 people |
African Mango
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small improvement in blood glucose | Improves (the measure goes down) | Small effect | 40 people |
DHEA
- Blood Flow: improves
- Estrogen: changes; see studies
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Flow Small Increase | Improves (the measure goes up) | Small effect | 24 people | |||
| Estrogen | Changes; see studies | 8 studies | 36 people | |||
| Testosterone | Improves (the measure goes up) | 3 studies | 36 people | |||
| Muscle Mass | Improves (the measure goes up) | 2 studies | 118 people | |||
| Serum DHEA | Improves (the measure goes up) | 2 studies | 12 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 60 people | |||
| IGF-1 | Improves (the measure goes up) | 1 study | 24 people | |||
| Body Fat | Improves (the measure goes down) | 130 people | ||||
| Glycemic Control | Improves (the measure goes up) | 12 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 154 people | ||||
| Insulin | Changes; see studies | 24 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 36 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 24 people | ||||
| Total cholesterol | Improves (the measure goes down) | 12 people | ||||
| Triglycerides | Improves (the measure goes down) | 142 people |
L-Carnitine
- Anti-Oxidant Enzyme Profile: improves
- High-density lipoprotein (HDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile Small Increase | Improves (the measure goes up) | Small effect | 12 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 12 studies | 30 people | |||
| Total cholesterol | Improves (the measure goes down) | 6 studies | 30 people | |||
| Blood glucose | Improves (the measure goes down) | 5 studies | 2,467 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 5 studies | 12 people | |||
| Triglycerides | Improves (the measure goes down) | 4 studies | 30 people | |||
| Insulin | Changes; see studies | 3 studies | 1,631 people | |||
| Muscle Mass | Improves (the measure goes up) | 3 studies | 12 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 61 people | |||
| Oxygen Uptake | Improves (the measure goes up) | 3 studies | 12 people | |||
| Free Fatty Acids | Improves (the measure goes up) | 2 studies | 35 people | |||
| Interleukin 6 | Improves (the measure goes down) | 2 studies | 169 people | |||
| Liver Enzymes | Changes; see studies | 2 studies | 40 people | |||
| Respiratory Exchange Ratio | Improves (the measure goes up) | 2 studies | 40 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 337 people | |||
| Body Fat | Improves (the measure goes down) | 1 study | 12 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 891 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 8 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 1,766 people | |||
| Hematocrit | Improves (the measure goes up) | 1 study | 10 people | |||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 10 people | |||
| Plasma Nitrate | Improves (the measure goes up) | 1 study | 15 people | |||
| Weight | Improves (the measure goes down) | 1 study | 12 people | |||
| Basophil Count | Improves (the measure goes up) | 10 people | ||||
| Bilirubin | Changes; see studies | 10 people | ||||
| Blood Flow | Improves (the measure goes up) | 30 people | ||||
| C-Peptide | Improves (the measure goes up) | 15 people | ||||
| Carbohydrate Oxidation | Improves (the measure goes up) | 23 people | ||||
| Creatinine | Improves (the measure goes up) | 10 people | ||||
| Glycemic Control | Improves (the measure goes up) | 38 people | ||||
| Glycerol | Improves (the measure goes up) | 12 people | ||||
| Heart Rate | Improves (the measure goes down) | 27 people | ||||
| Hemoglobin | Improves (the measure goes up) | 10 people | ||||
| Hydration (Total Body Water) | Improves (the measure goes up) | 12 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 1,449 people | ||||
| Ketone Bodies | Improves (the measure goes up) | 5 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 10 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 20 people | ||||
| Monocyte Count | Improves (the measure goes up) | 10 people | ||||
| Muscle protein synthesis (MPS) | Improves (the measure goes up) | 12 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 30 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 12 people | ||||
| Serum Albumin | Improves (the measure goes up) | 10 people | ||||
| Urea | Improves (the measure goes up) | 10 people | ||||
| Uric Acid | Improves (the measure goes down) | 10 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 10 people |
Pomegranate seed oil
- High-density lipoprotein (HDL): improves
- Triglycerides: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) Small Improvement | Improves (the measure goes up) | Small effect | 30 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 30 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 30 people |
Black Pepper
- Thermogenesis: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Thermogenesis TRPV1 activation increases thermogenesis; modest effect on metabolic rate in humans | Improves (the measure goes up) | Small effect | 40 people |
Fructose
- Triglycerides: improves
- Uric Acid: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Triglycerides High fructose intake increases blood triglycerides, especially in hypercaloric conditions | Improves (the measure goes down) | Moderate effect | 800 people | |||
| Uric Acid Fructose metabolism increases uric acid production | Improves (the measure goes down) | Moderate effect | 400 people |
Krill Oil
- Apolipoprotein A: improves
- C-Reactive Protein (CRP): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A Small Decrease | Improves (the measure goes down) | Small effect | 115 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 115 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 115 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 115 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 115 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 115 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 115 people | ||||
| Triglycerides | Improves (the measure goes down) | 115 people |
Eleuthero
- DNA Damage: improves
- Heart Rate: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA Damage Small Improvement | Improves (the measure goes down) | Small effect | 40 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 31 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 40 people | |||
| Fat Oxidation | Improves (the measure goes up) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 40 people | ||||
| Immunity | Improves (the measure goes up) | 31 people | ||||
| Liver Enzymes | Changes; see studies | 40 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 40 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 40 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 40 people |
Alpha-Lipoic Acid
- Blood Pressure
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect on blood pressure | NoneNo effect | 3 studies | 16 people |
Hesperidin
- Blood glucose
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 2 studies | 1,023 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 525 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 525 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 296 people | |||
| Blood Pressure | Improves (the measure goes down) | 338 people | ||||
| HbA1c | Improves (the measure goes down) | 318 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 569 people | ||||
| Insulin | Changes; see studies | 318 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 318 people | ||||
| Intercellular Adhesion Molecule 1 | Changes; see studies | 296 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 296 people | ||||
| sE-Selectin | Improves (the measure goes up) | 296 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 241 people | ||||
| Triglycerides | Improves (the measure goes down) | 569 people | ||||
| Vascular Adhesion Protein-1 | Improves (the measure goes up) | 296 people | ||||
| Waist circumference | Improves (the measure goes down) | 116 people | ||||
| Weight | Improves (the measure goes down) | 457 people |
Vitamin C
- Aerobic Exercise Metrics
- HbA1c: improves
- Cortisol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Aerobic Exercise Metrics No effect | NoneNo effect | 2 studies | 7 people | |||
| HbA1c | Improves (the measure goes down) | 9 studies | 488 people | |||
| Cortisol | Improves (the measure goes down) | 5 studies | 31 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 5 studies | 112 people | |||
| Triglycerides | Improves (the measure goes down) | 5 studies | 80 people | |||
| Blood Flow | Improves (the measure goes up) | 4 studies | 34 people | |||
| Blood glucose | Improves (the measure goes down) | 3 studies | 875 people | |||
| Exercise-Induced Oxidation | Changes; see studies | 2 studies | 23 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 16 people | |||
| Muscle Damage | Changes; see studies | 2 studies | 16 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 80 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 476 people | |||
| DNA Damage | Changes; see studies | 1 study | 73 people | |||
| Exercise Adaptations | Improves (the measure goes up) | 1 study | 39 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 21 people | |||
| Mineral Bioaccumulation | Improves (the measure goes up) | 1 study | 45 people | |||
| Plasma Vitamin C | Improves (the measure goes up) | 1 study | 89 people | |||
| Protection from Smoking | Improves (the measure goes up) | 1 study | 30 people | |||
| Resistin | Improves (the measure goes up) | 1 study | 80 people | |||
| Exercise-Induced Immune Suppression | Improves (the measure goes up) | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 80 people | ||||
| Insulin | Changes; see studies | 233 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 6 people | ||||
| LDL Oxidation | Improves (the measure goes down) | 30 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 80 people |
European Raspberry
- Blood glucose
- C-Reactive Protein (CRP)
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 1 study | 9 people | |||
| C-Reactive Protein (CRP) No effect | NoneNo effect | 9 people | ||||
| HbA1c | Improves (the measure goes down) | 9 people | ||||
| Insulin | Changes; see studies | 9 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 9 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 9 people |
Quercetin
- Anaerobic Capacity
- Exercise-induced Stress Response: improves
- Rating of Perceived Exertion: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity No effect | NoneNo effect | 1 study | 15 people | |||
| Exercise-induced Stress Response | Improves (the measure goes down) | 1 study | 8 people | |||
| Rating of Perceived Exertion | Improves (the measure goes up) | 1 study | 15 people | |||
| Interleukin 6 | Improves (the measure goes down) | 15 people | ||||
| Intestinal Permeability | Improves (the measure goes up) | 8 people | ||||
| Uric Acid | Improves (the measure goes down) | 15 people |
Conjugated Linoleic Acid
- Appetite
- Adiponectin
- Body Fat: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Appetite No effect | NoneNo effect | 1 study | 62 people | |||
| Adiponectin No effect | NoneNo effect | 59 people | ||||
| Body Fat | Improves (the measure goes down) | 7 studies | 303 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 6 studies | 367 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 6 studies | 198 people | |||
| Weight | Improves (the measure goes down) | 6 studies | 309 people | |||
| Muscle Mass | Improves (the measure goes up) | 5 studies | 278 people | |||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 139 people | |||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 35 people | |||
| Liver Enzymes | Changes; see studies | 2 studies | 132 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 122 people | |||
| DNA Damage | Changes; see studies | 1 study | 24 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 35 people | |||
| Inflammation | Improves (the measure goes down) | 1 study | 32 people | |||
| Blood glucose | Improves (the measure goes down) | 167 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 75 people | ||||
| Fat Oxidation | Improves (the measure goes up) | 23 people | ||||
| Insulin | Changes; see studies | 103 people | ||||
| Leptin | Improves (the measure goes up) | 44 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 183 people | ||||
| Triglycerides | Improves (the measure goes down) | 229 people |
Black Cohosh
- C-Reactive Protein (CRP)
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 124 people |
Epigallocatechin Gallate
- C-Reactive Protein (CRP)
- Interleukin 6
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 1 study | 152 people | |||
| Interleukin 6 No effect | NoneNo effect | 44 people |
PQQ
- Blood glucose
- C-Reactive Protein (CRP): improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 1 study | 10 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 10 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 10 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 10 people | ||||
| TMAO | Improves (the measure goes up) | 10 people | ||||
| Triglycerides | Improves (the measure goes down) | 10 people |
Alpha-Linolenic Acid (ALA)
- Blood glucose
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect on blood glucose | NoneNo effect | 1 study | 18,243 people |
Rhodiola Rosea
- Blood Pressure
- Creatine Kinase: changes; see studies
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure No effect | NoneNo effect | 1 study | 15 people | |||
| Creatine Kinase | Changes; see studies | 12 people | ||||
| Heart Rate | Improves (the measure goes down) | 15 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 12 people | ||||
| Muscle Damage | Changes; see studies | 12 people | ||||
| Muscle Oxygenation | Improves (the measure goes up) | 15 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 15 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 12 people |
Pyruvate
- Body Fat
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat No effect | NoneNo effect | 1 study | 14 people | |||
| Weight | Improves (the measure goes down) | 5 studies | 14 people |
Docosahexaenoic Acid
- B Cell Count
- Pre-Eclampsia Risk: changes; see studies
- Infant Death Risk: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| B Cell Count No effect | NoneNo effect | 1 study | 12 people | |||
| Pre-Eclampsia Risk | Changes; see studies | 1 study | 2,399 people | |||
| Infant Death Risk | Improves (the measure goes down) | 2,399 people | ||||
| Inflammation | Improves (the measure goes down) | 12 people | ||||
| T Cell Count | Improves (the measure goes up) | 12 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 12 people |
Hemp Protein
- High-density lipoprotein (HDL)
- Low-density lipoprotein (LDL): improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 14 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 2 studies | 14 people | |||
| Triglycerides | Improves (the measure goes down) | 14 people |
Pterostilbene
- Blood glucose
- Liver Enzymes: changes; see studies
- Kidney Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 215 people | ||||
| Liver Enzymes | Changes; see studies | 1 study | 215 people | |||
| Kidney Function | Improves (the measure goes up) | 215 people |
Fish Oil
- Apolipoprotein A
- Triglycerides: improves
- High-density lipoprotein (HDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 50 people | ||||
| Triglycerides | Improves (the measure goes down) | 24 studies | 364 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 7 studies | 314 people | |||
| Weight | Improves (the measure goes down) | 7 studies | 6 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 4 studies | 252 people | |||
| Inflammation | Improves (the measure goes down) | 4 studies | 242 people | |||
| Insulin | Changes; see studies | 4 studies | 193 people | |||
| Cell Adhesion Factors | Improves (the measure goes down) | 2 studies | 458 people | |||
| Cortisol | Improves (the measure goes down) | 2 studies | 36 people | |||
| HbA1c | Improves (the measure goes down) | 2 studies | 50 people | |||
| TNF-Alpha | Improves (the measure goes down) | 2 studies | 77 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 6 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 1,132 people | |||
| Interleukin 2 | Improves (the measure goes up) | 1 study | 77 people | |||
| Leukotriene B5 | Improves (the measure goes up) | 1 study | 12 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1 study | 304 people | |||
| Muscle Mass | Improves (the measure goes up) | 1 study | 6 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 50 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 50 people | ||||
| Blood glucose | Improves (the measure goes down) | 193 people | ||||
| Body Fat | Improves (the measure goes down) | 6 people | ||||
| Fructosamine | Changes; see studies | 19 people | ||||
| Glycemic Control | Improves (the measure goes up) | 143 people | ||||
| Interleukin 1-beta | Improves (the measure goes down) | 77 people | ||||
| Interleukin 5 | Improves (the measure goes up) | 77 people | ||||
| Leukotriene B4 | Improves (the measure goes up) | 12 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 6 people | ||||
| Prostaglandin J2a | Improves (the measure goes up) | 10 people | ||||
| Thromboxane B2 | Improves (the measure goes up) | 10 people | ||||
| Total cholesterol | Improves (the measure goes down) | 304 people |
Calcium
- Free Testosterone
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Free Testosterone No effect | NoneNo effect | 30 people |
Flaxseed
- Adiponectin
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 284 people | ||||
| Leptin | Improves (the measure goes up) | 2 studies | 284 people |
Coenzyme Q10
- Adiponectin
- Anaerobic Capacity
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 14 people | ||||
| Anaerobic Capacity No effect | NoneNo effect | 18 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 9 studies | 1,501 people | |||
| Blood Pressure | Improves (the measure goes down) | 4 studies | 1,831 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 4 studies | 2,387 people | |||
| Blood glucose | Improves (the measure goes down) | 3 studies | 2,157 people | |||
| Anti-Oxidant Enzyme Profile | Improves (the measure goes up) | 2 studies | 60 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 1,145 people | |||
| HbA1c | Improves (the measure goes down) | 2 studies | 1,505 people | |||
| Inflammation | Improves (the measure goes down) | 2 studies | 14 people | |||
| Interleukin 6 | Improves (the measure goes down) | 2 studies | 880 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 2,616 people | |||
| Exercise Capacity | Improves (the measure goes up) | 1 study | 23 people | |||
| Exercise-Induced Oxidation | Changes; see studies | 1 study | 41 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 2,409 people | |||
| Insulin | Changes; see studies | 1,234 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 988 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 23 people | ||||
| Sperm Count | Improves (the measure goes up) | 60 people | ||||
| Sperm Quality | Improves (the measure goes up) | 60 people | ||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 694 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 721 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 835 people | ||||
| Triglycerides | Improves (the measure goes down) | 2,443 people |
Black seed
- Adiponectin
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 39 people |
Vitamin B6
- Adrenocorticotropic Hormone
- Growth Hormone: improves
- Prolactin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenocorticotropic Hormone No effect | NoneNo effect | 10 people | ||||
| Growth Hormone | Improves (the measure goes up) | 1 study | 10 people | |||
| Prolactin | Improves (the measure goes up) | 1 study | 10 people | |||
| Cortisol | Improves (the measure goes down) | 10 people |
Green Tea Extract
- Blood glucose
- Insulin: changes; see studies
- Fat Oxidation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 1,819 people | ||||
| Insulin | Changes; see studies | 7 studies | 1,819 people | |||
| Fat Oxidation | Improves (the measure goes up) | 5 studies | 50 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 313 people | |||
| Iron Absorption | Improves (the measure goes up) | 1 study | 30 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1 study | 103 people | |||
| Metabolic Rate | Improves (the measure goes up) | 1 study | 31 people | |||
| Estrogen | Changes; see studies | 103 people | ||||
| Glycemic Control | Improves (the measure goes up) | 23 people | ||||
| HbA1c | Improves (the measure goes down) | 1,819 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 1,819 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 42 people | ||||
| Testosterone | Improves (the measure goes up) | 103 people |
Chromium
- Adiponectin
- Weight: improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 25 people | ||||
| Weight | Improves (the measure goes down) | 12 studies | 159 people | |||
| Glycemic Control | Improves (the measure goes up) | 9 studies | 48 people | |||
| Blood glucose | Improves (the measure goes down) | 6 studies | 112 people | |||
| Muscle Mass | Improves (the measure goes up) | 5 studies | 143 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 2 studies | 16 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 25 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 25 people | |||
| Insulin | Changes; see studies | 1 study | 87 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 25 people | |||
| Body Fat | Improves (the measure goes down) | 143 people | ||||
| Glycogen | Improves (the measure goes up) | 16 people | ||||
| Glycogen Resynthesis | Improves (the measure goes up) | 16 people | ||||
| Triglycerides | Improves (the measure goes down) | 25 people |
Japanese Knotweed
- Blood glucose
- Glycemic Control
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 20 people | ||||
| Glycemic Control No effect | NoneNo effect | 20 people | ||||
| Triglycerides | Improves (the measure goes down) | 1 study | 20 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 20 people | ||||
| Inflammation | Improves (the measure goes down) | 20 people | ||||
| Insulin | Changes; see studies | 20 people | ||||
| Leptin | Improves (the measure goes up) | 20 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 20 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 20 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 20 people | ||||
| Total cholesterol | Improves (the measure goes down) | 20 people |
Red Clover Extract
- Apolipoprotein A
- High-density lipoprotein (HDL): improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 31 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 6 studies | 31 people | |||
| Testosterone | Improves (the measure goes up) | 2 studies | 43 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 31 people | |||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 1 study | 43 people | |||
| Blood glucose | Improves (the measure goes down) | 31 people | ||||
| Estrogen | Changes; see studies | 43 people | ||||
| Glycemic Control | Improves (the measure goes up) | 74 people | ||||
| Insulin | Changes; see studies | 31 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 31 people | ||||
| Triglycerides | Improves (the measure goes down) | 31 people |
Bitter orange
- Alertness
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Alertness No effect | NoneNo effect | 50 people |
Reishi
- Anti-Oxidant Enzyme Profile
- Immunity: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile No effect | NoneNo effect | 18 people | ||||
| Immunity | Improves (the measure goes up) | 3 studies | 18 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| DNA Damage | Changes; see studies | 18 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 18 people | ||||
| Liver Enzymes | Changes; see studies | 18 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 18 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people |
Tetradecyl Thioacetic Acid
- Blood glucose
- Heart Rate: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
| Blood Pressure | Improves (the measure goes down) | 18 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 18 people | ||||
| Kidney Function | Improves (the measure goes up) | 18 people | ||||
| Liver Enzymes | Changes; see studies | 18 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people |
Vitamin E
- Anti-Oxidant Enzyme Profile
- Oxidative Stress Biomarkers: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anti-Oxidant Enzyme Profile No effect | NoneNo effect | 88 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 3 studies | 72 people | |||
| Total cholesterol | Improves (the measure goes down) | 2 studies | 368 people | |||
| Triglycerides | Improves (the measure goes down) | 2 studies | 332 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1 study | 88 people | |||
| Liver Enzymes | Changes; see studies | 1 study | 167 people | |||
| Neutrophil Count | Improves (the measure goes up) | 1 study | 32 people | |||
| Serum T4 | Improves (the measure goes up) | 1 study | 351 people | |||
| Weight | Improves (the measure goes down) | 1 study | 120 people | |||
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 148 people | |||
| Arterial Stiffness | Improves (the measure goes down) | 36 people | ||||
| Bilirubin | Changes; see studies | 88 people | ||||
| Bleeding Time | Changes; see studies | 319 people | ||||
| Blood glucose | Improves (the measure goes down) | 120 people | ||||
| Blood Pressure | Improves (the measure goes down) | 72 people | ||||
| Hematocrit | Improves (the measure goes up) | 88 people | ||||
| Homocysteine | Improves (the measure goes down) | 88 people | ||||
| Immunity | Improves (the measure goes up) | 32 people | ||||
| Kidney Function | Improves (the measure goes up) | 47 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 124 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 216 people | ||||
| Serum Cobalamin | Improves (the measure goes up) | 88 people | ||||
| Serum Folate | Improves (the measure goes up) | 88 people | ||||
| Serum T3 | Improves (the measure goes up) | 323 people | ||||
| Sexual Function | Improves (the measure goes up) | 184 people |
Bulbine Natalensis
- Kidney Function
- Liver Enzymes: worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Kidney Function No effect (but limited data) | NoneNo effect | 36 people | ||||
| Liver Enzymes Small Detriment (elevation = harm) | Worsens (the measure goes up) | Small effect | 36 people |
Alcohol
- Estrogen
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Estrogen No effect on estrogen | NoneNo effect | 17 people |
Vitamin K
- Adiponectin
- Insulin Resistance: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 42 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 2 studies | 1,548 people | |||
| Weight | Improves (the measure goes down) | 2 studies | 1,548 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 1,548 people | |||
| Blood Pressure | Improves (the measure goes down) | 1 study | 1,548 people | |||
| Insulin | Changes; see studies | 1 study | 1,548 people | |||
| Body Fat | Improves (the measure goes down) | 439 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,548 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 421 people | ||||
| Glycemic Control | Improves (the measure goes up) | 42 people | ||||
| HbA1c | Improves (the measure goes down) | 1,548 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 421 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 1,548 people | ||||
| Osteoprotegerin | Improves (the measure goes up) | 379 people | ||||
| Total cholesterol | Improves (the measure goes down) | 1,548 people | ||||
| Triglycerides | Improves (the measure goes down) | 1,548 people | ||||
| Waist circumference | Improves (the measure goes down) | 439 people |
Riboflavin (Vitamin B2)
- C-Reactive Protein (CRP)
- Homocysteine: improves
- Ferritin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) No effect | NoneNo effect | 42 people | ||||
| Homocysteine | Improves (the measure goes down) | 4 studies | 172 people | |||
| Ferritin | Improves (the measure goes up) | 42 people | ||||
| Uric Acid | Improves (the measure goes down) | 42 people |
Betaine
- Blood glucose
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 42 people |
Nicotinamide Mononucleotide
- Blood glucose
- Insulin Resistance: improves
- Serum NAD+ Levels: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 513 people | ||||
| Insulin Resistance | Improves (the measure goes down) | 2 studies | 513 people | |||
| Serum NAD+ Levels | Improves (the measure goes up) | 1 study | 513 people | |||
| HbA1c | Improves (the measure goes down) | 513 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 513 people | ||||
| Insulin | Changes; see studies | 513 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 513 people | ||||
| Total cholesterol | Improves (the measure goes down) | 513 people | ||||
| Triglycerides | Improves (the measure goes down) | 513 people | ||||
| Weight | Improves (the measure goes down) | 513 people |
Arginine
- Ammonia
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Ammonia No effect | NoneNo effect | 10 people |
Nicotine
- Blood glucose
- Blood Pressure: improves
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 34 people | ||||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 12 people | |||
| Glycemic Control | Improves (the measure goes up) | 1 study | 58 people | |||
| Insulin | Changes; see studies | 1 study | 34 people | |||
| Cortisol | Improves (the measure goes down) | 34 people | ||||
| Growth Hormone | Improves (the measure goes up) | 34 people |
Tart Cherry Juice
- Blood glucose
- Uric Acid: improves
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 58 people | ||||
| Uric Acid | Improves (the measure goes down) | 2 studies | 58 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 58 people | ||||
| Erythrocyte Sedimentation Rate | Improves (the measure goes down) | 58 people | ||||
| Insulin | Changes; see studies | 58 people | ||||
| Microbiome | Improves (the measure goes up) | 58 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 58 people |
Citrulline
- Blood glucose
- Growth Hormone: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 17 people | ||||
| Growth Hormone | Improves (the measure goes up) | 2 studies | 25 people | |||
| Insulin | Changes; see studies | 1 study | 37 people | |||
| Plasma Arginine | Improves (the measure goes up) | 1 study | 8 people | |||
| Creatinine | Improves (the measure goes up) | 17 people | ||||
| IGF-1 | Improves (the measure goes up) | 12 people | ||||
| Muscle protein synthesis (MPS) | Improves (the measure goes up) | 12 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 17 people | ||||
| Plasma Glutamine | Improves (the measure goes up) | 29 people | ||||
| Urea | Improves (the measure goes up) | 17 people |
Black Chokeberry
- Blood glucose
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 523 people |
Colostrum
- Anaerobic Capacity
- Weight: improves
- IGF-1: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anaerobic Capacity No effect | NoneNo effect | 51 people | ||||
| Weight | Improves (the measure goes down) | 5 studies | 51 people | |||
| IGF-1 | Improves (the measure goes up) | 2 studies | 51 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 1 study | 10 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 20 people | |||
| Cortisol | Improves (the measure goes down) | 10 people |
Maitake
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Trend toward BP reduction; not statistically significant | Improves (the measure goes down) | Small effect | 25 people |
Melatonin
- Adrenaline
- Blood Pressure: improves
- Exercise-Induced Oxidation: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adrenaline No effect | NoneNo effect | 14 people | ||||
| Blood Pressure | Improves (the measure goes down) | 5 studies | 14 people | |||
| Exercise-Induced Oxidation | Changes; see studies | 2 studies | 20 people | |||
| Growth Hormone | Improves (the measure goes up) | 2 studies | 18 people | |||
| Blood Flow | Improves (the measure goes up) | 14 people | ||||
| Cortisol | Improves (the measure goes down) | 10 people | ||||
| Heart Rate | Improves (the measure goes down) | 14 people | ||||
| Inflammation | Improves (the measure goes down) | 20 people | ||||
| Muscle Damage | Changes; see studies | 20 people | ||||
| Noradrenaline | Improves (the measure goes up) | 14 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 20 people | ||||
| Prolactin | Improves (the measure goes up) | 10 people |
Brown Seaweed Extract
- Blood glucose
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 23 people |
Curcumin
- Apolipoprotein A
- Blood glucose: improves
- Triglycerides: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein A No effect | NoneNo effect | 80 people | ||||
| Blood glucose | Improves (the measure goes down) | 18 studies | 3,048 people | |||
| Triglycerides | Improves (the measure goes down) | 9 studies | 3,364 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 6 studies | 24 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 5 studies | 1,276 people | |||
| Weight | Improves (the measure goes down) | 5 studies | 80 people | |||
| Total cholesterol | Improves (the measure goes down) | 4 studies | 822 people | |||
| Liver Enzymes | Changes; see studies | 3 studies | 1,329 people | |||
| Blood Pressure | Improves (the measure goes down) | 2 studies | 1,186 people | |||
| Insulin | Changes; see studies | 2 studies | 581 people | |||
| Arterial Stiffness | Improves (the measure goes down) | 1 study | 44 people | |||
| Blood Flow | Improves (the measure goes up) | 1 study | 44 people | |||
| Interleukin 6 | Improves (the measure goes down) | 1 study | 1,005 people | |||
| Iron Absorption | Improves (the measure goes up) | 1 study | 10 people | |||
| Prostate-Specific Antigen | Improves (the measure goes up) | 1 study | 85 people | |||
| Apolipoprotein B | Improves (the measure goes down) | 80 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 2,789 people | ||||
| Bone-specific Alkaline Phosphatase | Improves (the measure goes up) | 230 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1,716 people | ||||
| Glycemic Control | Improves (the measure goes up) | 80 people | ||||
| HbA1c | Improves (the measure goes down) | 1,196 people | ||||
| Heart Rate | Improves (the measure goes down) | 156 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 1,087 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 152 people | ||||
| Prostate Cancer Risk | Improves (the measure goes down) | 85 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 1,025 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 529 people |
D-Aspartic Acid
- Body Fat
- Estrogen
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat No effect | NoneNo effect | 20 people | ||||
| Estrogen No effect | NoneNo effect | 20 people | ||||
| Testosterone | Improves (the measure goes up) | 2 studies | 44 people | |||
| Free Testosterone | Improves (the measure goes up) | 24 people | ||||
| Muscle Mass | Improves (the measure goes up) | 20 people | ||||
| Weight | Improves (the measure goes down) | 20 people |
Glutathione
- DNA Damage
- Oxidative Stress Biomarkers: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| DNA Damage No effect | NoneNo effect | 39 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 1 study | 39 people |
Cocoa Extract
- Adiponectin
- High-density lipoprotein (HDL): improves
- Blood Pressure: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin No effect | NoneNo effect | 20 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 13 studies | 439 people | |||
| Blood Pressure | Improves (the measure goes down) | 10 studies | 253 people | |||
| Blood glucose | Improves (the measure goes down) | 5 studies | 61 people | |||
| Triglycerides | Improves (the measure goes down) | 3 studies | 439 people | |||
| Blood Flow | Improves (the measure goes up) | 2 studies | 100 people | |||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 2 studies | 76 people | |||
| Platelet Aggregation | Changes; see studies | 2 studies | 148 people | |||
| Blood Lactate (Exercise) | Changes; see studies | 1 study | 14 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 1 study | 41 people | |||
| Fat Oxidation | Improves (the measure goes up) | 1 study | 83 people | |||
| Adrenocorticotropic Hormone | Improves (the measure goes up) | 34 people | ||||
| Aerobic Exercise Metrics | Improves (the measure goes up) | 28 people | ||||
| Anaerobic Capacity | Improves (the measure goes up) | 14 people | ||||
| Cell Adhesion Factors | Improves (the measure goes down) | 20 people | ||||
| Cortisol | Improves (the measure goes down) | 34 people | ||||
| Exercise-Induced Oxidation | Changes; see studies | 34 people | ||||
| Glucagon | Changes; see studies | 20 people | ||||
| Glycemic Control | Improves (the measure goes up) | 115 people | ||||
| Heart Rate | Improves (the measure goes down) | 98 people | ||||
| Homocysteine | Improves (the measure goes down) | 19 people | ||||
| IL-1Ra | Improves (the measure goes down) | 20 people | ||||
| Insulin | Changes; see studies | 77 people | ||||
| Interleukin 10 | Improves (the measure goes up) | 20 people | ||||
| Interleukin 6 | Improves (the measure goes down) | 34 people | ||||
| Leptin | Improves (the measure goes up) | 20 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 439 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 34 people | ||||
| Plasma Vitamin E | Improves (the measure goes up) | 28 people | ||||
| Rating of Perceived Exertion | Improves (the measure goes up) | 34 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 20 people | ||||
| Total cholesterol | Improves (the measure goes down) | 570 people | ||||
| Uric Acid | Improves (the measure goes down) | 19 people | ||||
| Weight | Improves (the measure goes down) | 84 people |
Lactobacillus reuteri
- Bilirubin
- Blood Pressure: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 124 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 124 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 124 people | |||
| Blood glucose | Improves (the measure goes down) | 124 people | ||||
| Hematocrit | Improves (the measure goes up) | 124 people | ||||
| Hemoglobin | Improves (the measure goes up) | 124 people | ||||
| Liver Enzymes | Changes; see studies | 124 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 124 people | ||||
| Weight | Improves (the measure goes down) | 124 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 124 people |
Elderberry
- Blood glucose
- Carbohydrate Oxidation: improves
- Fat Oxidation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 10 people | ||||
| Carbohydrate Oxidation | Improves (the measure goes up) | 1 study | 10 people | |||
| Fat Oxidation | Improves (the measure goes up) | 10 people | ||||
| Metabolic Rate | Improves (the measure goes up) | 10 people |
S-adenosylmethionine
- Homocysteine: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Homocysteine | Improves (the measure goes down) | 3 studies | 29 people |
Stinging Nettle
- Inflammation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Inflammation | Improves (the measure goes down) | 2 studies | 20 people |
Glutamine
- Exercise Tolerance: improves
- Insulin: changes; see studies
- Blood glucose: worsens
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise Tolerance | Improves (the measure goes up) | 2 studies | 13 people | |||
| Insulin | Changes; see studies | 2 studies | 12 people | |||
| Blood glucose Small Detriment | Worsens (the measure goes up) | Small effect | 12 people |
Vanadium
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control | Improves (the measure goes up) | 2 studies | 30 people |
Nitrate
- Exercise Performance During Hypoxia: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Exercise Performance During Hypoxia | Improves (the measure goes up) | 2 studies | 9 people |
Cat's claw
- White Blood Cell Count: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| White Blood Cell Count | Improves (the measure goes up) | 1 study | 4 people |
Vitamin D
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| HbA1c | Improves (the measure goes down) | 1 study | 9 people |
Horny Goat Weed
- Estrogen: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Estrogen | Changes; see studies | 1 study | 8 people |
Resveratrol
- Fat Oxidation: improves
- Anaerobic Capacity: worsens
- Glycogen: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fat Oxidation | Improves (the measure goes up) | 1 study | 16 people | |||
| Anaerobic Capacity Small Detriment | Worsens (the measure goes down) | Small effect | 16 people | |||
| Glycogen | Improves (the measure goes up) | 16 people | ||||
| Oxygen Uptake | Improves (the measure goes up) | 16 people |
TUDCA
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insulin Resistance | Improves (the measure goes down) | 1 study | 20 people |
Grains of Paradise
- Metabolic Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Metabolic Rate | Improves (the measure goes up) | 1 study | 19 people |
Omega-3 Fatty Acids
- Glycemic Control: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control | Improves (the measure goes up) | 1 study | 618 people |
Prescription medicines and peptides studied, for context
Ipamorelin
- Growth Hormone Release: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Growth Hormone Release Ipamorelin potently stimulates growth hormone release in a dose-dependent manner, with effects comparable to GHRP-6 but without affecting cortisol or ACTH levels. | Improves (the measure goes up) | Large effect | 11 studies |
MOTS-c
- Insulin Sensitivity: improves
- Glucose Metabolism: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insulin Sensitivity MOTS-c treatment prevented age-dependent and high-fat-diet-induced insulin resistance in mice. Human studies show plasma MOTS-c levels correlate positively with insulin sensitivity in lean individuals. | Improves (the measure goes up) | Large effect | 11 studies | |||
| Glucose Metabolism MOTS-c improves glucose metabolism in skeletal muscle by enhancing GLUT4 translocation via AMPK activation, reducing hyperglycemia and hyperinsulinemia in diet-induced obese mice. | Improves (the measure goes down) | Large effect | 11 studies |
Sermorelin
- Growth Hormone Release: improves
- IGF-1 Levels: changes; see studies
- Insulin Sensitivity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Growth Hormone Release Sermorelin nearly doubled 12-hour mean GH release in elderly men and elevated peak GH amplitude. Effects were sustained with the majority of GH release preserved at night in physiological patterns. | Improves (the measure goes up) | Large effect | 11 studies | |||
| IGF-1 Levels Sermorelin elevated IGF-1 levels in elderly men in a dose-dependent manner, approaching levels seen in younger men. Elevations persisted for 2 weeks after stopping treatment. | Changes; see studies | Moderate effect | 11 studies | |||
| Insulin Sensitivity A significant increase in insulin sensitivity occurred in elderly men (P < 0.05) following 4 months of GHRH analog treatment, though not in women. | Improves (the measure goes up) | Moderate effect | 1 study |
Tesamorelin
- Growth Hormone Release: improves
- IGF-1 Levels: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Growth Hormone Release Tesamorelin stimulates significant increases in endogenous pulsatile GH secretion, with preserved physiological release patterns. | Improves (the measure goes up) | Large effect | 8 studies | |||
| IGF-1 Levels Treatment produces significant increases in IGF-1 levels, mediating downstream metabolic and cognitive effects. | Changes; see studies | Moderate effect | 8 studies |
GHRP-6
- Appetite Stimulation: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Appetite Stimulation Notable Increase | Improves (the measure goes up) | Large effect | 5 studies | 140 people |
Humanin
- Insulin Sensitivity: improves
- Glucose-Stimulated Insulin Secretion: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Insulin Sensitivity Intra-cerebroventricular and peripheral humanin significantly improved insulin sensitivity in rodent studies, described as one of the most potent insulin-sensitizing agents tested. | Improves (the measure goes up) | Large effect | 4 studies | |||
| Glucose-Stimulated Insulin Secretion Potent humanin analogs increase glucose-stimulated insulin secretion through enhanced beta-cell metabolism, with potential applications in diabetes treatment. | Changes; see studies | Moderate effect | 4 studies |
AOD-9604
- Fat Mass Reduction (Animal): improves
- Insulin Sensitivity
- Cholesterol Profile: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fat Mass Reduction (Animal) >50% reduction in weight gain in obese mice | Improves (the measure goes down) | Large effect | 7 studies | 160 people | ||
| Insulin Sensitivity No adverse effect on insulin sensitivity | NoneNo effect | 7 studies | 120 people | |||
| Cholesterol Profile Small improvement | Improves (the measure goes down) | Small effect | 7 studies | 300 people |
Key findings
- Blood glucoseImproves (the measure goes down)
- AdrenalineImproves (the measure goes up)
- Anti-Oxidant Enzyme ProfileImproves (the measure goes up)
Safety notes in the studies
- No adverse effect on insulin sensitivity
Shop the evidence-backed picks
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
The supplements graded A or B for Metabolic Health. Each opens third-party tested products for that supplement.
- Grade A
- Grade B
- Grade B
- Grade B
- Grade B
- Grade B
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
100 studies from PubMed
- Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.
- Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials.
- Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis.
- Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.
- The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of Sparus aurata Following IFA Treatment.
- The Role of HMB Supplementation in Enhancing the Effects of Resistance Training in Older Adults: A Systematic Review and Meta-Analysis on Muscle Quality, Body Composition, and Physical Function.
- Plasma Humanin and Non-Coding RNAs as Biomarkers of Endothelial Dysfunction in Rheumatoid Arthritis: A Pilot Study.
- Humanin attenuates metabolic, toxic, and traumatic neuropathic pain in mice by protecting against oxidative stress and increasing inflammatory cytokine.
- HUMANIN produced by human efferocytic macrophages promotes the resolution of inflammation.
- Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes
- MOTS-C levels ın ındividuals with and without obesity and ıts association with ınflammation, insulin resistance and endothelial dysfunction.
- MOTS-c in type 2 diabetes mellitus: From risk factors to cardiac complications and potential treatment.
- MOTS-c mimics remote ischemic preconditioning in protecting against lung ischemia-reperfusion injury by alleviating endothelial barrier dysfunction.
- MOTS-c as a Potential Diagnostic-prognostic Biomarker for Myocardial Infarction.
- MOTS-c relieves hepatocellular carcinoma resistance to TRAIL-induced apoptosis under hypoxic conditions by activating MEF2A.
- MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes.
- A mitochondrial-derived peptide MOTS-c contributes to the protective effect against brain injury associated with LPS-induced sepsis by strengthening the blood-brain barrier's ultrastructure.
- MOTS-c attenuates airway barrier dysfunction in allergic asthma by inhibiting epithelial apoptosis via Nrf2 pathway.
- MOTS-c Promotes Glycolysis via AMPK-HIF-1α-PFKFB3 Pathway to Ameliorate Cardiopulmonary Bypass-induced Lung Injury.
- A Mighty Mitochondrial Microprotein: The Protective Role of MOTS-c in Acute Lung Injury.
- MOTS-c mimics exercise to combat diabetic liver fibrosis by targeting Keap1-Nrf2-Smad2/3.
- Effects of omega-3 fatty acids on chronic pain: a systematic review and meta-analysis.
- The effects of probiotic supplementation on cardiometabolic health in patients with prediabetes: a systematic review, meta-analysis, and GRADE assessment.
- Lactococcus lactis strain Plasma activates plasmacytoid dendritic cells and mitigates common cold-like symptoms in healthy adults: a meta-analysis of individual participant data.
- Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.
- Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity
- Metabolic dysfunction-associated steatotic liver disease in people with HIV.
- Effect of vitamin D supplementation for major adverse cardiovascular events: a meta-analysis based on randomised controlled trials.
- Effects of Withania somnifera supplementation on cognitive function: A systematic review and meta-analysis
- Effects of Ashwagandha (Withania somnifera) Supplementation on Exercise Performance: A Systematic Review and Meta-Analysis
- Ashwagandha (Withania somnifera) and its withanolides attenuate oxidative and inflammatory signaling in the nervous system
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Effect of a Dietary Supplement Containing Dry Artichoke and Bergamot Extracts on Metabolic and Vascular Risk Factors
- The Effect of Antioxidant Polyphenol Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis.
- The Effectiveness of Curcumin, Resveratrol, and Silymarin on MASLD: A Systematic Review and Meta-Analysis.
- The Effects of Fisetin on Reducing Biological Aging: A Pilot Study
- Senolytics To slOw Progression of Sepsis (STOP-Sepsis) in elderly patients: Study protocol for a multicenter, randomized, adaptive allocation clinical trial
- Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms
- Effects of β-hydroxy-β-methylbutyrate (HMB) supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials.
- [Gly14]-Humanin ameliorates high glucose-induced endothelial senescence via SIRT6.
- Impaired Expression of Humanin during Adrenocortical Carcinoma.
- Humanin ameliorates TBI-related cognitive impairment by attenuating mitochondrial dysfunction and inflammation.
- Humanin variant P3S is associated with longevity in APOE4 carriers and resists APOE4-induced brain pathology.
- Humanin-G Ameliorates Hemorrhage-Induced Acute Lung Injury in Mice Through AMPKα1-Dependent and -Independent Mechanisms.
- Humanin's impact on pain markers and neuronal viability in diabetic neuropathy model.
- Mitochondrial-derived microprotein MOTS-c attenuates immobilization-induced skeletal muscle atrophy by suppressing lipid infiltration.
- The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study.
- MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis.
- Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study.
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination.
- Neuroprotective Mechanism of MOTS-c in TBI Mice: Insights from Integrated Transcriptomic and Metabolomic Analyses.
- Mitochondria-derived peptide is an effective target for treating streptozotocin induced painful diabetic neuropathy through induction of activated protein kinase/peroxisome proliferator-activated receptor gamma coactivator 1alpha -mediated mitochondrial biogenesis.
- The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression.
- The correlation between mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis.
- Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.
- Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis of randomized controlled trials
- Clinical effects of Ashwagandha (Withania somnifera) root extract on human health: A systematic review of reviews
- A Comprehensive Review on Pharmacological Activity of Withania somnifera (Ashwagandha)
- Inhibition of ghrelin activity by the receptor antagonist [D-Lys3]-GHRP-6 enhances hepatic fatty acid oxidation and gluconeogenesis in a growing pig model.
- Humanin and Its Pathophysiological Roles in Aging: A Systematic Review
- A novel link between chronic inflammation and humanin regulation in children.
- Mitochondrial stress and mitokines in aging.
- Humanin and Its Pathophysiological Roles in Aging: A Systematic Review.
- S14G-humanin confers cardioprotective effects against chronic adrenergic and pressure overload-induced heart failure in mice.
- S14G-humanin alleviates acute lung injury by inhibiting the activation of NF-κB.
- Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases
- Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging
- The protective effect of the mitochondrial-derived peptide MOTS-c on LPS-induced septic cardiomyopathy.
- MOTS-c Serum Concentration Positively Correlates with Lower-Body Muscle Strength and Is Not Related to Maximal Oxygen Uptake-A Preliminary Study.
- Orally administered MOTS-c analogue ameliorates dextran sulfate sodium-induced colitis by inhibiting inflammation and apoptosis.
- MOTS-c and aerobic exercise induce cardiac physiological adaptation via NRG1/ErbB4/CEBPβ modification in rats.
- The mitochondrial-derived peptide MOTS-c suppresses ferroptosis and alleviates acute lung injury induced by myocardial ischemia reperfusion via PPARγ signaling pathway.
- The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury.
- Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study.
- The Mitochondrial-Derived Peptide (MOTS-c) Interacted with Nrf2 to Defend the Antioxidant System to Protect Dopaminergic Neurons Against Rotenone Exposure.
- Adropin and MOTS-c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?
- Serum MOTS-C Levels are Decreased in Obese Children and Associated with Vascular Endothelial Function.
- Mitochondrial-Derived Peptide MOTS-c Ameliorates Spared Nerve Injury-Induced Neuropathic Pain in Mice by Inhibiting Microglia Activation and Neuronal Oxidative Damage in the Spinal Cord via the AMPK Pathway.
- MOTS-c: A potential anti-pulmonary fibrosis factor derived by mitochondria.
- Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice.
- Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.
- GHRH agonist MR-409 protects β-cells from streptozotocin-induced diabetes.
- Effects of Ashwagandha (Withania somnifera) on Testosterone Levels: A Systematic Review and Meta-Analysis
- Ashwagandha (Withania somnifera)-Current Research on the Health-Promoting Activities: A Narrative Review
- Withania somnifera (L.) Dunal: A review of chemical composition and pharmacological activities
- A network meta-analysis on the comparative effect of nutraceuticals on lipid profile in adults
- Does creatine supplementation improve glycemic control and insulin resistance in healthy and diabetic patients? A systematic review and meta-analysis.
- The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
- Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection
- Humanin and diabetes mellitus: A review of in vitro and in vivo studies.
- The protective effects of S14G-humanin on gestational diabetes mellitus symptoms.
- Humanin vivoliver and tumor bioimpedance measured with biopsy needle.
- An evidence of Humanin-like peptide and Humanin mediated cryosurvival of spermatozoa in buffalo bulls.
- Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD).
- [Gly14]-Humanin inhibits an angiotensin II-induced vascular smooth muscle cell phenotypic switch via ameliorating intracellular oxidative stress.
- Circulating humanin is lower in coronary artery disease and is a prognostic biomarker for major cardiac events in humans.
- Cardio-protective role of Humanin in myocardial ischemia-reperfusion.
- Humanin-induced autophagy plays important roles in skeletal muscle function and lifespan extension.
- MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases
- The MOTS-c K14Q polymorphism in the mtDNA is associated with muscle fiber composition and muscular performance.